ALX Oncology Holdings Inc. - Common Stock — Quarterly Cash Flow (NASDAQ:ALXO) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Documents

Quarterly Annual

Total assets 120.9 M95.32 M82.72 M59.05 M178.33 M160.82 M Total liabilities 32.6 M30.91 M37.92 M33.06 M26.98 M24.63 M Total equity 88.3 M64.42 M44.8 M25.98 M151.35 M136.19 M Total liabilities & shareholders' equities 120.9 M95.32 M82.72 M59.05 M178.33 M160.82 M Total debt 8.23 M7 M11.05 M10.71 M9.49 M10.71 M Net debt 8.23 M7 M-54.86 M-40.26 M-137.03 M-127.52 M

News

Is ALX Oncology Holdings (ALXO) Stock Outpacing Its Medical Peers This Year?

BIAF Stock Plunges 77% in 3 Months: Should You Still Hold or Sell?

ALX Oncology: Rebuilding From Critical Setbacks (NASDAQ:ALXO)

Is ALX Oncology Holdings (ALXO) Outperforming Other Medical Stocks This Year?

ALX Oncology Holdings Inc. (ALXO) Q1 2026 Earnings Call Transcript

ALX Oncology Holdings Inc. 2026 Q1 - Results - Earnings Call Presentation (NASDAQ:ALXO) 2026-05-08

bioAffinity Stock Surges 113.8% in 3 Months: What's Driving the Rally?

ALDX Crashes 71% as FDA Issues Third CRL for Dry Eye Disease Drug NDA

CTMX Stock Rallies on Strong Phase I Colorectal Cancer Study Data

IBRX Stock Jumps on Progress in NK Cell Therapy Production

JNJ's Bladder Cancer Therapy Meets Key Goal in Early-Stage Study

RARE's DTX301 Meets First Key Goal in Phase III OTC Deficiency Study